middle.news
Nexsen Advances StrepSure FDA Pathway and Secures Asia-Pacific Grants
10:18am on Tuesday 28th of April, 2026 AEST
•
Healthcare
Read Story
Nexsen Advances StrepSure FDA Pathway and Secures Asia-Pacific Grants
10:18am on Tuesday 28th of April, 2026 AEST
Key Points
FDA Q-Submission confirms 510(k) pathway for StrepSure
HK$6 million IGNITE grant supports Hong Kong clinical validation and manufacturing
AU$0.5 million grant funds neonatal Group B Streptococcus diagnostic development
ISO 13485 Quality Management System certification progressing toward completion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nexsen (ASX:NXN)
OPEN ARTICLE